gms | German Medical Science

26. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie (GAA)

Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie

21.11. - 22.11.2019, Bonn/Bad Godesberg

Needs assessment for an interprofessional academic program for medication safety

Meeting Abstract

  • author presenting/speaker Julia Thevissen - Institute of Pharmacy, Department of Clinical Pharmacy, University of Bonn, Bonn, Germany
  • author Anna Böhmer - Institute of Pharmacy, Department of Clinical Pharmacy, University of Bonn, Bonn, Germany
  • author Radia Al Ghaddioui - Center for Evaluation and Methods, University of Bonn, Bonn, Germany
  • author Katharina Olejniczak - Center for Evaluation and Methods, University of Bonn, Bonn, Germany
  • author Dorothee Dartsch - CaP Campus Pharmazie GmbH, Hamburg, Germany
  • author Britta Hänisch - Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany
  • author Anna Laven - German Society for Interprofessional Collaboration in Health Care (InZIG), Berlin, Germany
  • author Cornelia Mahler - Institute of Health Sciences, Department of Nursing Science, University Hospital Tübingen, Tübingen, Germany
  • author Norbert Paeschke - Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany
  • author Hanna Seidling - Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital Heidelberg, Heidelberg, Germany
  • author Birgitta Weltermann - Institute of General Practice and Family Medicine, University Hospital Bonn, Bonn, Germany
  • author Ronja Woltersdorf - Institute of Pharmacy, Department of Clinical Pharmacy, University of Bonn, Bonn, Germany
  • corresponding author Ulrich Jaehde - Institute of Pharmacy, Department of Clinical Pharmacy, University of Bonn, Bonn, Germany

Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie e.V. (GAA). 26. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie. Bonn/Bad Godesberg, 21.-22.11.2019. Düsseldorf: German Medical Science GMS Publishing House; 2019. Doc19gaa20

doi: 10.3205/19gaa20, urn:nbn:de:0183-19gaa202

Veröffentlicht: 19. November 2019

© 2019 Thevissen et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Background: An academic program on medication safety may enhance education and training of multiplicators sensitizing health care professionals for patients’ medication risks. Such a program may systematically minimize medication risks in routine health care. Aim of this project is to assess the need for an academic program on medication safety and to develop an innovative curriculum.

Materials and methods: An interprofessional working group guided the curriculum development process. An analysis of existing programs on medication safety was followed by a needs assessment consisting of in-depth telephone interviews with potential students, lecturers, employers and stake holders. An online survey integrating these results was conducted in August 2019. The invitation to participate in the survey was distributed by associations and societies of health care professionals involved in the medication process.

Results: A total of 687 persons participated in the survey, of which 64.6% were pharmacists, 10.4% nurses und 8.9% physicians. 34.2% regarded themselves as potential students, 31.0% as potential lecturers and 28.1% as potential employers. 95.9% of the participants rated an interprofessional academic program as useful or rather useful. The following topics were regarded as most needed: medication process/errors (94.5%), medication safety-enhancing measures (94.2%) and interprofessional communication (87.7%).

Conclusion: The needs assessment indicates a high interest in an academic program on medication safety among potential students, lecturers, employers and stake holders in health care. Based on the results, a competency-based curriculum for an interprofessional, non-consecutive Master program integrating certificate courses will be designed.

Acknowledgement: The financial support by the Federal Ministry of Health (BMG) is gratefully acknowledged (SINA project: https://www.klinische-pharmazie.info/sina).